BPC-157 Acetate Spray — Research Grade Nasal Delivery
BPC-157 Acetate Spray provides research-grade BPC-157 in acetate salt form delivered via nasal spray, combining the enhanced stability of the acetate formulation with the convenience of intranasal delivery for research protocols. BPC-157 is a synthetic pentadecapeptide (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) with one of the broadest preclinical research profiles of any research peptide, spanning gastrointestinal protection, tendon and ligament repair, muscle healing, and neurological research applications. HPLC verified at ≥99% purity per batch.
Research Background
BPC-157 Acetate’s enhanced formulation stability makes it particularly suited to spray delivery, where buffer pH and compound stability over the product’s shelf life are critical. Published preclinical research documents BPC-157’s activity via multiple administration routes, including evidence that intranasal delivery produces measurable systemic and CNS effects in rodent models. The compound’s interaction with the NO system, VEGF-mediated angiogenesis, and GH receptor upregulation represent well-documented mechanisms across published studies.
Compound Specifications
- Format: Nasal spray solution (acetate salt)
- Purity: ≥99% (HPLC verified)
- Active compound: BPC-157 Acetate
- Storage: 2–8°C refrigerated, protected from light
- Molecular Weight: 1419.5 Da
Certificate of Analysis
Third-party tested by independent ISO-certified laboratories. HPLC and MS/MS validation performed per batch. COA available on request.
For research and laboratory use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
